Drug and Device Law (Free subscription) | 7 hours ago
Here's today's question: What do we think of McQuiston v. Boston Scientific Corp., No. 5:07-cv-01723-TS-MLH, slip op. (W.D. La. Nov. 19, 2009) ( link here )? Here's today's answer: We love it! But not for the reasons you'd think. Here's the deal: On September 1, 2006, Dr. Thomas Brown performed an angioplasty and stent procedure on James McQuiston. Boston Scientific manufactured the stent. McQuiston...
Drug and Device Law (Free subscription) | 5 hours ago
Professor Ben Zipursky (Fordham) just published a guest post over at Torts Prof Blog ruminating about why the Supreme Court found preemption in the context of medical devices that had undergone premarket approval in Riegel v. Medtronic, but did not find preemption in the context of prescription drugs on the facts of Wyeth v. Levine. That's an interesting post, and we commend it to you. We have a couple...
kansascity.com (Free subscription) | 21/11/2009
strong>MONDAY:</strong> Existing home sales; earnings reports from Campbell Soup, Hewlett-Packard, Tyson Foods. <strong>TUESDAY:</strong> Preliminary third quarter gross domestic product; November consumer confidence; earnings reports from Barnes & Noble, Borders Group, Brown Shoe, Heinz, Hormel, Medtronic, TiVo.
PR News Wire (Free subscription) | 20/11/2009
MINNEAPOLIS, Nov. 20 /PRNewswire/ -- Medtronic, Inc. today announced the kick-off of an educational campaign aimed at raising awareness among women of overactive bladder (OAB), a serious condition that can severely impact patients' lives. This new campaign, conducted in partnership with leading patient advocacy groups, including The Accidental Sisterhood, Red Hot Mamas and Women's Health Foundation,...
Red Orbit (Free subscription) | 20/11/2009
MINNEAPOLIS, Nov. 20 /PRNewswire/ -- Medtronic, Inc. today announced the kick-off of an educational campaign aimed at raising awareness among women of overactive bladder (OAB), a serious condition that can severely impact patients' lives.
Business Wire (Free subscription) | 19/11/2009
MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. (NYSE: MDT), chairman and CEO Bill Hawkins today issued the following statement regarding the U.S. Senate’s revised proposal regarding a medical device industry fee released yesterday. This new proposal amends the Senate Finance Committee’s earlier proposed $40 billion fee on the medical device industry. Sens. Dianne Feinstein and Barbara Boxer...
Business Wire (Free subscription) | 19/11/2009
MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. received today an International Business Leadership Award from the Greater Miami Chamber of Commerce in recognition for its significant impact on the economy of the state of Florida in the Education & Training category. Awards were presented to one small and one large business in each of the following categories: Business Retention & Expansion,...
Business Wire (Free subscription) | 19/11/2009
MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. (NYSE: MDT), chairman and CEO Bill Hawkins today issued the following statement regarding the U.S. Senate’s revised proposal regarding a medical device industry fee released yesterday. This new proposal amends the Senate Finance Committee’s earlier proposed $40 billion fee on the medical device industry. Sens. Amy Klobuchar and Al Franken were...
Business Wire (Free subscription) | 19/11/2009
MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. (NYSE: MDT), chairman and CEO Bill Hawkins today issued the following statement regarding the U.S. Senate’s revised proposal regarding a medical device industry fee released yesterday. This new proposal amends the Senate Finance Committee’s earlier proposed $40 billion fee on the medical device industry. Senator Evan Bayh was instrumental in...
DeviceSpace (Free subscription) | 19/11/2009
MINNEAPOLIS--(BUSINESS WIRE)--Continuing to drive innovation in endovascular aortic repair (EVAR), Medtronic, Inc. (NYSE: MDT - News), today announced the introduction of an imaging and visualization service for endovascular specialists who use the company’s market-leading portfolio of stent grafts to treat aortic aneurysms. Aortic aneurysms affect more than one million people in the United States...
NewsInferno (Free subscription) | 19/11/2009
Device maker giant, Medtronic, Inc., just announced that it received a warning letter from the U.S. Food & Drug Administration (FDA). According to the Twin Cities Business Journal, the letter came after an inspection of Medtronic’s Mounds View Cardiac Rhythm Disease Management site and concerned: “Corrective and preventative action and field-action timeliness, review and documentation...
MarketIntelligenceCenter.com (Free subscription) | 19/11/2009
Medtronic (NYSE: MDT) closed yesterday at $39.71. So far the stock has hit a 52-week low of $24.06 and 52-week high of $40.22. Medtronic stock has been showing support around 39.17 and resistance in the 40.37 range. Technical indicators for the stock are Bullish and S&P gives MDT a positive 4 STAR (out of 5) buy rating. MDT appears on the Investors Observer Volume Leaders list. For a hedged play...
Business Wire (Free subscription) | 19/11/2009
MINNEAPOLIS--(BUSINESS WIRE)--Continuing to drive innovation in endovascular aortic repair (EVAR), Medtronic, Inc. (NYSE: MDT), today announced the introduction of an imaging and visualization service for endovascular specialists who use the company’s market-leading portfolio of stent grafts to treat aortic aneurysms. Aortic aneurysms affect more than one million people in the United States alone...
DeviceSpace (Free subscription) | 18/11/2009
The Daily News -- Executives of Medtronic Inc. celebrated a $65 million expansion of its distribution center Tuesday morning that will allow the medical device company to ship additional products.
DeviceSpace (Free subscription) | 18/11/2009
The Company will respond to the letter within 15 days, as required. In addition, the Company has already begun to implement changes and put procedures in place related to each of the observations cited during the inspection, and any additional actions that may be required will be in place as quickly as possible. FDA noted in its warning letter to Medtronic that the Company’s promised corrective...
Videos